Total Payments
$5,534
2024 Payments
$547.83
Companies
33
Transactions
271
Medicare Patients
1,332
Medicare Billing
$112,083
Payment Breakdown by Category
Food & Beverage$4,900 (88.5%)
Travel$367.34 (6.6%)
Education$243.78 (4.4%)
Other$22.60 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,900 | 259 | 88.5% |
| Travel and Lodging | $367.34 | 2 | 6.6% |
| Education | $243.78 | 9 | 4.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22.60 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,028 | 68 | $0 (2024) |
| LivaNova USA, Inc. | $793.34 | 5 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $606.30 | 32 | $0 (2024) |
| Biogen, Inc. | $482.76 | 26 | $0 (2024) |
| Allergan, Inc. | $447.43 | 19 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $403.41 | 29 | $0 (2019) |
| UCB, Inc. | $256.57 | 10 | $0 (2018) |
| Lilly USA, LLC | $200.70 | 12 | $0 (2022) |
| Genentech USA, Inc. | $140.31 | 9 | $0 (2024) |
| SK Life Science, Inc. | $127.15 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $547.83 | 19 | ABBVIE INC. ($228.33) |
| 2023 | $816.48 | 45 | ABBVIE INC. ($593.28) |
| 2022 | $374.58 | 18 | ABBVIE INC. ($126.57) |
| 2021 | $140.61 | 8 | Allergan, Inc. ($42.36) |
| 2020 | $131.11 | 7 | Teva Pharmaceuticals USA, Inc. ($54.64) |
| 2019 | $546.03 | 30 | Biogen, Inc. ($146.07) |
| 2018 | $1,340 | 42 | LivaNova USA, Inc. ($793.34) |
| 2017 | $1,637 | 102 | Teva Pharmaceuticals USA, Inc. ($303.37) |
All Payment Transactions
271 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.16 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.20 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $93.71 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $33.13 | General |
| 08/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.12 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: NEUROSCIENCE | ||||||
| 05/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $80.84 | General |
| Category: Immunology | ||||||
| 04/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $82.14 | General |
| Category: Central Nervous System | ||||||
| 03/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $81.73 | General |
| Category: Neurology | ||||||
| 01/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2023 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $72.27 | General |
| Category: Neurology | ||||||
| 10/20/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: PAIN | ||||||
| 10/19/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 373 | 450 | $88,909 | $31,684 |
| 2022 | 8 | 290 | 373 | $71,479 | $25,891 |
| 2021 | 6 | 297 | 364 | $69,027 | $27,472 |
| 2020 | 14 | 372 | 436 | $66,961 | $27,035 |
Total Patients
1,332
Total Services
1,623
Medicare Billing
$112,083
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 22 | 28 | $8,155 | $2,995 | 36.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 27 | 27 | $7,545 | $2,824 | 37.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $5,198 | $2,076 | 39.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 25 | $3,389 | $1,392 | 41.1% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 20 | 20 | $1,840 | $899.80 | 48.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 83 | 109 | $15,540 | $6,370 | 41.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 34 | 34 | $7,605 | $2,938 | 38.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 31 | 40 | $7,520 | $2,913 | 38.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 15 | 15 | $4,875 | $2,413 | 49.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 58 | 66 | $5,380 | $2,187 | 40.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 14 | 22 | $3,674 | $1,706 | 46.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 13 | 14 | $3,120 | $1,246 | 39.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 12 | 12 | $2,664 | $1,243 | 46.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 11 | 11 | $3,250 | $1,096 | 33.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 12 | 16 | $1,872 | $920.92 | 49.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 15 | 15 | $1,590 | $907.58 | 57.1% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Facility | 2020 | 17 | 23 | $2,088 | $776.57 | 37.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 16 | $2,048 | $692.54 | 33.8% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2020 | 15 | 15 | $1,380 | $689.79 | 50.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 12 | 13 | $1,090 | $489.94 | 44.9% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Facility | 2020 | 15 | 15 | $3,265 | $445.80 | 13.7% |
About Dr. Amanda Nies, D.O
Dr. Amanda Nies, D.O is a Neurological Surgery healthcare provider based in Holland, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2009. The National Provider Identifier (NPI) number assigned to this provider is 1639307093.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amanda Nies, D.O has received a total of $5,534 in payments from pharmaceutical and medical device companies, with $547.83 received in 2024. These payments were reported across 271 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($4,900).
As a Medicare-enrolled provider, Nies has provided services to 1,332 Medicare beneficiaries, totaling 1,623 services with total Medicare billing of $112,083. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurological Surgery
- Location Holland, MI
- Active Since 06/24/2009
- Last Updated 01/12/2018
- Taxonomy Code 207T00000X
- Entity Type Individual
- NPI Number 1639307093
Products in Payments
- VNS Therapy (Device) $793.34
- UBRELVY (Drug) $486.95
- QULIPTA (Drug) $344.77
- GILENYA (Drug) $286.16
- BOTOX (Biological) $283.79
- TYSABRI (Biological) $217.65
- EMGALITY (Drug) $200.70
- BOTOX THERAPEUTIC (Biological) $182.71
- Briviact (Drug) $179.03
- VUMERITY (Drug) $174.08
- APTIOM (Drug) $125.19
- AUSTEDO (Drug) $122.02
- OCREVUS (Biological) $119.58
- COPAXONE (Drug) $91.99
- TECFIDERA (Drug) $91.03
- VYVGART (Drug) $84.38
- Austedo XR (Drug) $82.14
- Zembrace (Drug) $81.62
- BRIUMVI (Drug) $80.84
- Vimpat (Drug) $77.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.